CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
Clinical trial NCT03572764 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03572764
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2021-11-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.